Dr. Zsofia Szep, MD

Dr. Szep practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Szep's NPI, 1588651491, was assigned on October 5, 2005. Dr. Szep graduated from Jefferson Medical College of Thomas Jefferson University in 2002. Dr. Szep holds Pennsylvania license MD426335.

Dr. Szep's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Szep's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Szep is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Szep to 1 more hospital and 1 medical group, each named with a free account. Dr. Szep's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Szep practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Szep's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Szep is licensed in Pennsylvania.

CMS data shows 203 Medicare services from Dr. Szep across 5 procedure codes in 2024, for 90 Medicare patients. Medicare paid $16,194 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Dr. Szep in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Szep's median patient age at 57, with 39% women.

In 2024, Dr. Szep wrote 143 Medicare Part D claims for 26 patients. 74% of them were for generic drugs. CMS names the drug for 48 of them, across 2 drugs with 11 or more claims each, at $140,527 in total drug cost. In 2023, CMS named 75 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Szep for performance year 2024, reported as part of a group. Dr. Szep accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Szep as offering telehealth.

Dmand AI links 19 papers to Dr. Szep, published from 2011 to 2024. 2019 was the busiest year, with 3. The most frequent topics are HIV Infections, Pre-Exposure Prophylaxis and Health Knowledge, Attitudes, Practice. Dr. Szep has published most often in J Neurovirol. Dr. Szep's most frequent co-authors are Jillian Tracey Baron, MD, Anuragh Reddy Gudur, MD and Joshua Ho.

Dmand AI links Dr. Szep to 1 clinical trial. Conditions studied include Medication Adherence and Patient Compliance.

CMS Open Payments shows 44 general payments to Dr. Szep from 5 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 59% of the total. Gilead Sciences, Inc. paid the most, $1,981.

Dr. Szep graduated from Jefferson Medical College of Thomas Jefferson University in 2002.